Mechanism-related circumvention of Cisplatin resistance in human ovarian-carcinoma cells by (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanediacarboxylato)-platinum (ii) monohydrate and modulation of its sensitivity by 12-o-tetradecanoylphorbol-13-acetate.